SPGI vs STRO
S&P Global Inc (SPGI) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
S&P Global Inc (SPGI) is a financial data & stock exchanges company listed on NYSE.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported SPGI revenue for 2025-12-31 was $15.34B. Net income was $4.47B. Revenue was up 7.9% from 2024-12-31 to 2025-12-31. SPGI currently screens at market cap $127.50B and trailing P/E 27.2.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
SPGI currently screens at market cap $127.50B and trailing P/E 27.2. STRO currently screens at market cap $470.8M.
Not investment advice. Open the SPGI and STRO stock pages for the full models.
Not investment advice.